Product Development and Analytical Services for Complex Drug Products & Combination Systems.
SmaBio Labs partners with pharmaceutical and biotech teams to design, optimize, and scale formulations from ophthalmics and long-acting injectables to drug-device combination products. Science-driven, regulator-ready, partner-first.
One Partner. One Strategy. End-to-End Development.
From early-stage discovery through product and process development, analytical services, and commercialization readiness, SmaBio Labs provides integrated scientific support with regulatory precision.
Flexible synthesis support for API intermediates, reference standards and impurities.
API intermediatesReference standardsImpurities
Quality, Process and Compliance
Why SmaBio Labs
A skilled team and state-of-the-art facilities in Research Triangle Park, NC, designed to turn scientific potential into meaningful progress.
01
Quality
FDA-Registered Analytical Lab
Advanced analytical capabilities designed to support rigorous quality and regulatory requirements
Expert Analytical Services
Robust analytical solutions that support informed decisions throughout discovery and development programs
Stability
ICH Q1
Elemental impurities
ICH Q3D · USP <233>
Residual solvents
ICH Q3C
02
Process
Chemistry to Clinic
Seamlessly supporting product development from molecule characterization through CTM manufacturing
Immediate Capacity
Available capacity and responsive project initiation to help programs move forward without unnecessary delays
Complex Formulations
Specialized expertise in the design and development of complex drug products and combination systems
Framework
QbD
Defined
QTPP · CQAs · CPPs
Climatic zones
ICH I–IVb
03
Compliance
Successful Client Audits
Consistently earning sponsor confidence through successful audits and compliance excellence
Operations
U.S.-based
Clinical supply
cGMP CTM Phase I–II
Regulation
21 CFR cGMP
Cleanrooms
ISO 7/8 · ISO 5 BSC
Containment
HPAPI up to OEB 5
Development Pathway
QbD-Driven Product Development Pathway for Regulatory Alignment
From pre-formulation to launch, SmaBio Labs develops robust, compliant, patient-focused pharmaceutical solutions designed for successful development and scale-up.
Step 01
Pre-Formulation
Defining Product and Material Attributes to Guide Formulation and Development Strategies.
Physicochemical Characterization
Drug/Excipient Compatibility
Excipient Selection
Define QTPP and CQAs
Step 02
Formulation Development
Developing Robust Formulations to Support Product Performance, Quality, and Manufacturability.
Proof-of-Concept Batches
Lead Formulation Selection
Packaging Selection & Studies
Identify Critical Material Attributes (CMAs)
Step 03
Process Development
Designing Robust Manufacturing Processes to Support Consistent Product Quality and Scale-up.
Define Process Design
Define CPPs
Define Equipment Train
Step 04
Scale-Up and Stability
Confirming Product Robustness Through Scale-Up and Stability Studies.
Solutions, suspensions, emulsions, and lyophilized products require precision in sterility, solubility, and stability.
View capabilities for Sterile Formulations
Optimize drug solubility and formulation stability.
Maintain sterility throughout product development.
Control endotoxin levels, pH, and osmolality.
Support aseptic processing requirements.
Evaluate container-closure compatibility.
Provide stability studies and regulatory development support.
Ophthalmic Formulations
Ophthalmic formulations demand exceptional precision in sterility, stability, drug delivery, and patient comfort.
View capabilities for Ophthalmic Formulations
Develop eye drops, ointments, and ophthalmic gels.
Optimize drug solubility, stability, and ocular bioavailability.
Control pH, osmolality, and viscosity for patient comfort.
Ensure sterility and compatibility throughout product development.
Optimize excipients and delivery systems for effective ocular drug delivery.
Support formulation development, stability optimization, and regulatory readiness.
Topical Formulations
Topical formulations require the right balance of efficacy, texture, absorption, and skin safety.
View capabilities for Topical Formulations
Develop creams, gels, and ointments.
Optimize emulsifiers, gelling agents, and penetration enhancers.
Ensure APIs reach the intended skin layer while maintaining potency.
Optimize texture, spreadability, absorption, and release.
Minimize irritation and sensitization risks.
Conduct rigorous formulation and stability testing.
Support development from concept to commercial readiness.
Medical Devices
Medical device development requires careful consideration of product performance, safety, compatibility, and regulatory requirements.
View capabilities for Medical Devices
Product and formulation development support.
Material and excipient compatibility evaluation.
Performance and stability assessment.
Risk-based development and optimization.
Testing strategy and analytical support.
Regulatory documentation support.
Development support toward commercial readiness.
Transdermal Formulations
Transdermal patch development demands precision, from drug selection to skin compatibility.
View capabilities for Transdermal Formulations
Overcome skin’s natural barrier while ensuring stability and patient comfort.
Select drugs with optimal properties including low molecular weight, lipophilicity, and potency.
Design matrix polymers, adhesives, and enhancers for consistent drug release.
Minimize risks of skin irritation and sensitization.
Expertise in excipient screening, in-vitro permeation, and stability optimization.
End-to-end support for safe and scalable transdermal patch development.
Testimonials
What our partners say.
“
{{cur.quote}}
{{cur.slot}}
[Add client testimonial]
{{cur.initials}}
{{cur.name}}
{{cur.role}}
[Client name]
[Title, Company]
{{counter}} / {{total}}
Leadership
Meet Our Leadership
Meet the quality and scientific leaders guiding SmaBio Labs, with deep expertise across quality assurance, product development, analytical services and manufacturing